Hydroxyapatite Market Size, Share, and Trends 2024 to 2034

The global hydroxyapatite market size is calculated at USD 2.79 billion in 2025 and is forecasted to reach around USD 4.94 billion by 2034, accelerating at a CAGR of 6.54% from 2025 to 2034. The North America market size surpassed USD 1.00 billion in 2024 and is expanding at a CAGR of 6.62% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 5462
  • Category : Chemical and Material

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Hydroxyapatite Market 

5.1. COVID-19 Landscape: Hydroxyapatite Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hydroxyapatite Market, By Type

8.1. Hydroxyapatite Market Revenue and Volume, By Type

8.1.1 Nano-Size

8.1.1.1. Market Revenue and Volume Forecast 

8.1.2. Micro-Size

8.1.2.1. Market Revenue and Volume Forecast 

8.1.3. Greater Than Micrometres

8.1.3.1. Market Revenue and Volume Forecast 

Chapter 9. Global Hydroxyapatite Market, By Application

9.1. Hydroxyapatite Market Revenue and Volume, By Application

9.1.1. Orthopaedic

9.1.1.1. Market Revenue and Volume Forecast 

9.1.2. Dental Care

9.1.2.1. Market Revenue and Volume Forecast 

9.1.3. Plastic Surgery

9.1.3.1. Market Revenue and Volume Forecast 

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast 

Chapter 10. Global Hydroxyapatite Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, By Type 

10.1.2. Market Revenue and Volume Forecast, By Application 

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, By Type 

10.1.3.2. Market Revenue and Volume Forecast, By Application 

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, By Type 

10.1.4.2. Market Revenue and Volume Forecast, By Application 

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, By Type 

10.2.2. Market Revenue and Volume Forecast, By Application 

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, By Type 

10.2.3.2. Market Revenue and Volume Forecast, By Application 

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, By Type 

10.2.4.2. Market Revenue and Volume Forecast, By Application 

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, By Type 

10.2.5.2. Market Revenue and Volume Forecast, By Application 

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, By Type 

10.2.6.2. Market Revenue and Volume Forecast, By Application 

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, By Type 

10.3.2. Market Revenue and Volume Forecast, By Application 

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, By Type 

10.3.3.2. Market Revenue and Volume Forecast, By Application 

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, By Type 

10.3.4.2. Market Revenue and Volume Forecast, By Application 

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, By Type 

10.3.5.2. Market Revenue and Volume Forecast, By Application 

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, By Type 

10.3.6.2. Market Revenue and Volume Forecast, By Application 

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, By Type 

10.4.2. Market Revenue and Volume Forecast, By Application 

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, By Type 

10.4.3.2. Market Revenue and Volume Forecast, By Application 

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, By Type 

10.4.4.2. Market Revenue and Volume Forecast, By Application 

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, By Type 

10.4.5.2. Market Revenue and Volume Forecast, By Application 

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, By Type 

10.4.6.2. Market Revenue and Volume Forecast, By Application 

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, By Type 

10.5.2. Market Revenue and Volume Forecast, By Application 

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, By Type 

10.5.3.2. Market Revenue and Volume Forecast, By Application 

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, By Type 

10.5.4.2. Market Revenue and Volume Forecast, By Application 

Chapter 11. Company Profiles

11.1. APS Materials, Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Berkeley Advanced Biomaterials

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bioceramics

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. CAM Bioceramics

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. FLUIDINOVA

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Granulab (M) Sdn Bhd

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Merz Biomaterials

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Sangi Co., Ltd.H

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. SigmaGraft

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. SofSera Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global hydroxyapatite market size is expected to grow from USD 2.62 billion in 2024 to USD 4.94 billion by 2034.

The hydroxyapatite market is anticipated to grow at a CAGR of 6.54% between 2025 and 2034.

The major players operating in the hydroxyapatite market are APS Materials, Inc., Berkeley Advanced Biomaterials, Bioceramics, CAM Bioceramics, FLUIDINOVA, Granulab (M) Sdn Bhd, Merz Biomaterials, Sangi Co., Ltd.H, SigmaGraft, SofSera Corporation, Taihei Chemical Industrial Co. Ltd., Zimmer Biomet, and Others.

The driving factors of the hydroxyapatite market are the Increasing demand for biocompatible materials in healthcare is anticipated to drive the hydroxyapatite market in the coming years.

North America region will lead the global hydroxyapatite market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client